Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters










Publication year range
1.
Regul Pept ; 192-193: 35-44, 2014.
Article in English | MEDLINE | ID: mdl-25160855

ABSTRACT

The stomach produces acid, which may play an important role in the regulation of bone homeostasis. The aim of this study was to reveal signaling pathways in the gastric mucosa that involve the acid secretion and possibly the bone metabolism in CCK1 and/or CCK2 receptor knockout (KO) mice. Gastric acid secretion was impaired and the ECL cell signaling pathway was inhibited in CCK2 receptor KO mice but not in CCK1 receptor KO mice. However, in CCK1+2 receptor double KO mice the acid secretion in response to pylorus ligation-induced vagal stimulation and the ECL cell pathway were partially normalized, which was associated with an up-regulated pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1). The basal part of the gastric mucosa expressed parathyroid hormone-like hormone (PTHLH) in a subpopulation of likely ECL cells (and possibly other cells) and vitamin D3 1α hydroxylase probably in trefoil peptide2-immunoreactive cells. In conclusion, mice lacking CCK receptors exhibited a functional shift from the gastrin-CCK pathways to the neuronal pathway in control of the ECL cells and eventually the acid secretion. Taking the present data together with previous findings, we suggest a possible link between gastric PTHLH and vitamin D and bone metabolism.


Subject(s)
Gastric Mucosa/metabolism , Gene Expression Profiling , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin B/deficiency , Animals , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Real-Time Polymerase Chain Reaction , Receptor, Cholecystokinin A/genetics , Receptor, Cholecystokinin B/genetics
2.
Cell Physiol Biochem ; 32(6): 1878-90, 2013.
Article in English | MEDLINE | ID: mdl-24356325

ABSTRACT

BACKGROUND/AIMS: Cholecystokinin 1-receptor (CCK1-R) activation by long chain fatty acid (LCFA) absorption stimulates vago-vagal reflex pathways in the brain stem. The present study determines whether this reflex also activates the cholinergic anti-inflammatory pathway, a pathway known to modulate cytokine release during endotoxemia. METHODS: Mesenteric lymph was obtained from wild type (WT) and CCK1-R knockout (CCK1-R(-/-)) mice intraperitoneally challenged with Lipopolysaccharid (LPS) (endotoxemic lymph, EL) and intestinally infused with vehicle or LCFA-enriched solution. The lymph was analyzed for TNFα, IL-6 and IL-10 concentration and administered to healthy recipient mice via jugular infusion. Alveolar wall thickness, myeloperoxidase (MPO) and TUNEL positive cells were determined in lung tissue of recipient mice. RESULTS: LCFA infusion in WT mice reduced TNFα concentration in EL by 49% compared to vehicle infusion, but had no effect in CCK1-R(-/-) mice. EL significantly increased the alveolar wall thickness, the number of MPO-positive and TUNEL-positive cells compared to control lymph administration. LCFA infusion in WT, but not in CCK1R(-/-) mice, significantly reduced these pathological effects of EL. CONCLUSION: During endotoxemia enteral LCFA absorption reduces TNFα release into mesenteric lymph and attenuates histomorphologic parameters of lung dysfunction. Failure to elicit this effect in CCK1R(-/-) mice demonstrates that anti-inflammatory properties of LCFAs are mediated through CCK1-Rs.


Subject(s)
Lung/pathology , Receptor, Cholecystokinin A/metabolism , Animals , Endotoxemia/chemically induced , Endotoxemia/metabolism , Endotoxemia/pathology , Fatty Acids, Unsaturated , Interleukin-10/analysis , Interleukin-6/analysis , Lipopolysaccharides , Lymph Nodes/drug effects , Lymph Nodes/metabolism , Male , Mice , Mice, Knockout , Peroxidase/metabolism , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin A/genetics , Tumor Necrosis Factor-alpha/analysis
3.
Am J Physiol Regul Integr Comp Physiol ; 303(12): R1231-40, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-23115121

ABSTRACT

CCK is hypothesized to inhibit meal size by acting at CCK1 receptors (CCK1R) on vagal afferent neurons that innervate the gastrointestinal tract and project to the hindbrain. Earlier studies have shown that obese Otsuka Long-Evans Tokushima Fatty (OLETF) rats, which carry a spontaneous null mutation of the CCK1R, are hyperphagic and obese. Recent findings show that rats with CCK1R-null gene on a Fischer 344 background (Cck1r(-/-)) are lean and normophagic. In this study, the metabolic phenotype of this rat strain was further characterized. As expected, the CCK1R antagonist, devazepide, failed to stimulate food intake in the Cck1r(-/-) rats. Both Cck1r(+/+) and Cck1r(-/-) rats became diet-induced obese (DIO) when maintained on a high-fat diet relative to chow-fed controls. Cck1r(-/-) rats consumed larger meals than controls during the dark cycle and smaller meals during the light cycle. These effects were accompanied by increased food intake, total spontaneous activity, and energy expenditure during the dark cycle and an apparent reduction in respiratory quotient during the light cycle. To assess whether enhanced responsiveness to anorexigenic factors may contribute to the lean phenotype, we examined the effects of melanotan II (MTII) on food intake and body weight. We found an enhanced effect of MTII in Cck1r(-/-) rats to suppress food intake and body weight following both central and peripheral administration. These results suggest that the lean phenotype is potentially driven by increases in total spontaneous activity and energy expenditure.


Subject(s)
Energy Metabolism/physiology , Motor Activity/physiology , Phenotype , Receptor, Cholecystokinin A/deficiency , Thinness/physiopathology , Animals , Body Weight/drug effects , Body Weight/physiology , Devazepide/pharmacology , Eating/drug effects , Eating/physiology , Gene Deletion , Male , Models, Animal , Peptides, Cyclic/pharmacology , Rats , Rats, Inbred F344 , Rats, Mutant Strains , Receptor, Cholecystokinin A/antagonists & inhibitors , Receptor, Cholecystokinin A/genetics , Sequence Deletion/genetics , alpha-MSH/analogs & derivatives , alpha-MSH/pharmacology
4.
Physiol Behav ; 99(1): 109-17, 2010 Jan 12.
Article in English | MEDLINE | ID: mdl-19887078

ABSTRACT

CCK-1 receptor deficient Otsuka Long Evans Tokushima Fatty (OLETF) rats are hyperphagic, which leads to subsequent obesity and diabetes. Additionally, they have increased sham intake and enhanced preference for sucrose solutions relative to control, Long Evans Tokushima Otsuka (LETO) rats. To determine the effects of oil on ingestion, we first measured real feeding of various concentrations of oil emulsions (12.5, 25, 50, 75, and 100%) in rats that were fed ad libitum. Secondly, to isolate the orosensory compontent of oils from post-ingestive consequences, as well as determine the contribution of energy status, we measured sham feeding in OLETF and LETO rats using one-bottle acceptance tests while non-deprived and overnight food deprived. Finally, to assess the orosensory effects of nutritive and non-nutritive oils, we used two-bottle preference tests in sham fed OLETF and LETO rats. We found that real feeding resulted in increased intake of high oil concentrations for OLETF rats relative to LETO rats. Similarly, OLETF rats consumed significantly more of higher concentration corn oils than LETO while non-deprived sham feeding. Conversely, OLETF rats overconsumed low concentration corn oil compared to LETO during overnight deprived sham-feeding tests. In two-bottle sham-feeding preference tests, both non-deprived OLETF and LETO rats preferred corn to mineral oil. Collectively, these results show that increased oil intake in OLETF rats is driven by both peripheral deficits to satiation and altered orosensory sensitivity.


Subject(s)
Food Preferences/physiology , Oils/administration & dosage , Receptor, Cholecystokinin A/deficiency , Taste/drug effects , Taste/physiology , Analysis of Variance , Animals , Dose-Response Relationship, Drug , Feeding Behavior/physiology , Food Deprivation/physiology , Gastric Emptying/physiology , Glucose Tolerance Test , Rats , Rats, Inbred OLETF , Rats, Transgenic , Sucrose/administration & dosage , Sweetening Agents/administration & dosage
5.
Am J Physiol Regul Integr Comp Physiol ; 297(6): R1749-60, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19793959

ABSTRACT

Understanding the early factors affecting obesity development in males and females may help to prevent obesity and may lead to the discovery of more effective treatments for those already obese. The Otsuka Long-Evans Tokushima Fatty (OLETF) rat model of obesity is characterized by hyperphagia-induced obesity, due to a spontaneous lack of CCK(1) receptors. In the present study, we focused on the behavioral and physiological aspects of obesity development from weaning to adulthood. We examined body weight, feeding efficiency, fat pad [brown, retroperitoneal, inguinal and epydidimal (in males)] weight, inguinal adipocyte size and number, leptin and oxytocin levels, body mass index, waist circumference, and females' estrous cycle structure. In the males, central hypothalamic gene expression was also examined. OLETF rats presented overall higher fat and leptin levels, larger adipocytes, and increased waist circumference and BMI from weaning until adulthood, compared with controls. Analysis of developmental patterns of gene expression for hypothalamic neuropeptides revealed peptide-specific patterns that may underlie or be a consequence of the obesity development. Analysis of the developmental trajectories toward obesity within the OLETF strain revealed that OLETF females developed obesity in a more gradual manner than the males, presenting delayed obesity-related "turning points," with reduced adipocyte size but larger postweaning fat pads and increased adipocyte hyperplasia compared with the males. Intake decrease in estrus vs. proestrus was significantly less in OLETF vs. Long-Evans Tokushima Otsuka females. The findings highlight the importance of using different sex-appropriate approaches to increase the efficacy of therapeutic interventions in the treatment and prevention of chronic early-onset obesity.


Subject(s)
Aging , Feeding Behavior , Hyperphagia/physiopathology , Obesity/physiopathology , Rats, Inbred OLETF , Adipocytes/pathology , Adipose Tissue/pathology , Adipose Tissue/physiopathology , Age Factors , Aging/genetics , Aging/metabolism , Animals , Blood Glucose/metabolism , Body Mass Index , Body Weight , Chronic Disease , Disease Models, Animal , Disease Progression , Eating , Estrus , Female , Gene Expression Regulation, Developmental , Hyperphagia/genetics , Hyperphagia/metabolism , Hyperphagia/psychology , Hypothalamus/metabolism , Hypothalamus/physiopathology , Leptin/blood , Male , Neuropeptides/genetics , Obesity/genetics , Obesity/metabolism , Obesity/psychology , Oxytocin/blood , RNA, Messenger/metabolism , Rats , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin A/genetics
6.
Cell Metab ; 10(2): 99-109, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19656488

ABSTRACT

Cholecystokinin (CCK) is a peptide hormone that is released from the gut in response to nutrients such as lipids to lower food intake. Here we report that a primary increase of CCK-8, the biologically active form of CCK, in the duodenum lowers glucose production independent of changes in circulating insulin levels. Furthermore, we show that duodenal CCK-8 requires the activation of the gut CCK-A receptor and a gut-brain-liver neuronal axis to lower glucose production. Finally, duodenal CCK-8 fails to lower glucose production in the early onset of high-fat diet-induced insulin resistance. These findings reveal a role for gut CCK that lowers glucose production through a neuronal network and suggest that intestinal CCK resistance may contribute to hyperglycemia in response to high-fat feeding.


Subject(s)
Cholecystokinin/metabolism , Duodenum/metabolism , Glucose/metabolism , Nerve Net/physiology , Receptor, Cholecystokinin A/metabolism , Animals , Devazepide/pharmacology , Dietary Fats/pharmacology , Duodenum/innervation , Insulin/metabolism , Insulin Resistance , Male , Rats , Rats, Sprague-Dawley , Receptor, Cholecystokinin A/antagonists & inhibitors , Receptor, Cholecystokinin A/deficiency
7.
Brain Res ; 1255: 98-112, 2009 Feb 19.
Article in English | MEDLINE | ID: mdl-19111529

ABSTRACT

A large body of evidence has demonstrated that one mechanism by which cholecystokinin (CCK) inhibits food intake through activation of CCK1 receptors (CCK1R) on vagal afferent neurons that innervate the gastrointestinal tract and project to the hindbrain. OLETF rats, which carry a spontaneous null mutation of the CCK1R, are hyperphagic, obese, and predisposed to type 2 diabetes. Recently, by introgressing the OLETF-derived, CCK1R-null gene onto a Fischer 344 genetic background, we have been able to generate a CCK1R-deficient, congenic rat strain, F344.Cck1r(-/-), that in contrast to OLETF rats, possesses a lean and normoglycemic phenotype. In the present study, the behavioral and neurobiological phenotype of this rat strain was characterized more fully. As expected, intraperitoneal injections of CCK-8 inhibited intake of chow and Ensure Plus and induced Fos responses in the area postrema and the gelatinosus, commissural and medial subdivisions of the nucleus tractus solitarius of wild-type F344.Cck1r(+/+) rats, whereas CCK-8 was without effect on food intake or Fos induction in the F344.Cck1r(-/-) rats. F344.Cck1r(-/-) and F344.Cck1r(+/+) rats did not differ in body weight and showed comparable weight gain when maintained on Ensure Plus for 2 weeks. Also, no difference was found in 24-h food intake, and dark-phase meal frequency or meal size between F344.Cck1r(+/+) and F344.Cck1r(-/-) rats. As expected, blockade of endogenous CCK action at CCK1R increased food intake and blocked the effects of peripheral CCK-8 in wild-type F344.Cck1r(+/+) rats. These results confirm that in rats with a F344 background, CCK-1R mediates CCK-8-induced inhibition of food intake and Fos activation in the hindbrain and demonstrate that selective genetic ablation of CCK1R is not associated with altered meal patterns, hyperphagia, or excessive weight gain on a palatable diet.


Subject(s)
Body Weight/physiology , Cholecystokinin/pharmacology , Eating/physiology , Feeding Behavior/physiology , Peptide Fragments/pharmacology , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin A/genetics , Animals , Cholecystokinin/administration & dosage , Genotype , Immunohistochemistry , Injections, Intraperitoneal , Male , Peptide Fragments/administration & dosage , Polymerase Chain Reaction , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Inbred F344 , Rats, Transgenic , Receptor, Cholecystokinin A/metabolism
8.
J Neurosci ; 28(45): 11583-92, 2008 Nov 05.
Article in English | MEDLINE | ID: mdl-18987194

ABSTRACT

The intestinal hormones CCK and PYY3-36 inhibit gastric emptying and food intake via vagal afferent neurons. Here we report that CCK regulates the expression of Y2R, at which PYY3-36 acts. In nodose ganglia from rats fasted up to 48 h, there was a fivefold decrease of Y2R mRNA compared with rats fed ad libitum; Y2R mRNA in fasted rats was increased by administration of CCK, and by refeeding through a mechanism sensitive to the CCK1R antagonist lorglumide. Antibodies to Y2R revealed expression in both neurons and satellite cells; most of the former (89 +/- 4%) also expressed CCK1R. With fasting there was loss of Y2R immunoreactivity in CCK1R-expressing neurons many of which projected to the stomach, but not in satellite cells or neurons projecting to the ileum or proximal colon. Expression of a Y2R promoter-luciferase reporter (Y2R-luc) in cultured vagal afferent neurons was increased in response to CCK by 12.3 +/- 0.1-fold and by phorbol ester (16.2 +/- 0.4-fold); the response to both was abolished by the protein kinase C inhibitor Ro-32,0432. PYY3-36 stimulated CREB phosphorylation in rat nodose neurons after priming with CCK; in wild-type mice PYY3-36 increased Fos labeling in brainstem neurons but in mice null for CCK1R this response was abolished. Thus Y2R is expressed by functionally distinct subsets of nodose ganglion neurons projecting to the stomach and ileum/colon; in the former expression is dependent on stimulation by CCK, and there is evidence that PYY3-36 effects on vagal afferent neurons are CCK dependent.


Subject(s)
Cholagogues and Choleretics/pharmacology , Cholecystokinin/pharmacology , Gene Expression Regulation/drug effects , Neurons, Afferent/drug effects , Receptors, Neuropeptide Y/metabolism , Stomach/innervation , Vagus Nerve/cytology , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Cells, Cultured , Fasting/physiology , Hormone Antagonists/pharmacology , Humans , Male , Mice , Mice, Knockout , Nodose Ganglion/cytology , Oncogene Proteins v-fos/metabolism , Proglumide/analogs & derivatives , Proglumide/pharmacology , RNA, Messenger/metabolism , Rats , Receptor, Cholecystokinin A/deficiency , Receptors, Neuropeptide Y/genetics , Satiety Response/drug effects , Satiety Response/physiology
9.
FASEB J ; 22(5): 1479-90, 2008 May.
Article in English | MEDLINE | ID: mdl-18073333

ABSTRACT

Daily behaviors are strongly dominated by internally generated circadian rhythms, but the underlying mechanisms remain unclear. In mammals, photoentrainment of behaviors to light-dark cycles involves signaling from both intrinsically photosensitive retinal ganglion cells and classic photoreceptor pathways to the suprachiasmatic nucleus (SCN). How classic photoreceptor pathways work with the photosensitive ganglion cells, however, is not fully understood. Although cholecystokinin (CCK) peptide has been shown to be present in a variety of vertebrate retinas, its function at a systems level is also unknown. In the present study we examined a possible role of CCK-A receptors in photoentrainment using CCK-A receptor knockout mice. The lacZ reporter gene within a gene-knockout cassette revealed precise localization of CCK-A receptors in the circadian clock system. We demonstrated that CCK-A receptors were located predominately on glycinergic amacrine cells but were rarely found on SCN neurons. Moreover, Ca(2+) imaging analysis demonstrated that the CCK-A agonist, CCK-8 sulfate (CCK-8s), mobilized intracellular Ca(2+) in amacrine cells but not glutamate-receptive SCN neurons. Furthermore, light pulse-induced mPer1/mPer2 gene expression in SCN, behavioral phase shifts, and the pupillary reflex were significantly reduced in CCK-A receptor knockout mice. These data indicate a novel function of CCK-A receptors in the nonimage-forming photoreception presumably via amacrine cell-mediated signal transduction pathways.


Subject(s)
Amacrine Cells/physiology , Circadian Rhythm/physiology , Receptor, Cholecystokinin A/physiology , Animals , Light , Male , Mice , Mice, Knockout , Models, Neurological , Motor Activity/radiation effects , Receptor, Cholecystokinin A/deficiency , Reflex, Pupillary/physiology , Sincalide/analogs & derivatives , Sincalide/pharmacology , Suprachiasmatic Nucleus/cytology , Suprachiasmatic Nucleus/physiology , Suprachiasmatic Nucleus/radiation effects
12.
Brain Res Bull ; 74(5): 357-60, 2007 Oct 19.
Article in English | MEDLINE | ID: mdl-17845910

ABSTRACT

"Responder" Sprague-Dawley (SD) rats that were sensitive to electroacupuncture (EA) in an acute thermal pain test (i.e. tail flick latency [TFL] test) maintained sensitivity to EA in the warm allodynia test after peripheral nerve injury. Similarly, the "non-responder" SD rats that were insensitive to EA in the TFL test were also insensitive to EA in the allodynia test. The EA-induced analgesic effects in the TFL test were significantly higher in CCK-A receptor deficient, Otsuka Long-Evans Tokushima Fatty (OLETF) rats than in their littermates, Long-Evans Tokushima Otsuka (LETO) rats. Similarly, the anti-allodynic effects of EA were significantly greater in OLETF rats than in LETO rats. These results suggest that the individual differences in the sensitivity of acute pain behavior to EA were maintained in neuropathic pain behavior following peripheral nerve injury, and that CCK-A receptor expression plays an important role in mediating this phenomenon.


Subject(s)
Electroacupuncture/methods , Individuality , Pain Management , Pain/etiology , Peripheral Nervous System Diseases/complications , Animals , Behavior, Animal , Disease Models, Animal , Male , Pain Measurement , Rats , Rats, Inbred OLETF , Rats, Long-Evans , Rats, Sprague-Dawley , Reaction Time/physiology , Receptor, Cholecystokinin A/deficiency
13.
Neuroscience ; 148(2): 584-92, 2007 Aug 24.
Article in English | MEDLINE | ID: mdl-17681694

ABSTRACT

Accumulating evidence has indicated a link between dopamine signaling and obesity in both animals and humans. We have recently demonstrated heightened avidity to sapid sweet solutions in the obese cholecystokinin (CCK)-1 receptor deficient Otsuka Long Evans Tokushima fatty (OLETF) rat. To investigate the dopamine dependence and the respective contribution of D1 and D2 receptor subtypes in this phenomenon, real and sham intake of 0.3 M sucrose solution was compared between prediabetic, obese OLETF and age-matched lean Long-Evans Tokushima Otsuka (LETO) cohorts following peripheral (i.p.) administration of equimolar doses (50-800 nmol/kg) of the D1 (R-(+) 7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine, SCH23390) and D2 (raclopride) selective receptor antagonists. Both antagonists were potent in reducing sucrose intake in both strains with both drugs suppressing sham intake starting at lower doses than real intake (200 nmol/kg vs. 400 nmol/kg for SCH23390, and 400 nmol/kg vs. 600 nmol/kg for raclopride, respectively). Furthermore, when percent suppression of intake, a measure that controlled for the higher baseline sucrose intake by obese rats was analyzed, OLETF rats expressed an increased sensitivity to raclopride in reducing ingestion of sucrose with a 1.7- and 2.9-fold lower inhibitory dose threshold (ID50) for real and sham intake conditions, respectively, compared with LETO controls. In contrast, SCH23390 caused no differential strain effect with respect to dosage whether sucrose was real or sham fed. These findings demonstrate that D2 receptors are involved in heightened increased consumption of sucrose observed in the OLETF obese rat.


Subject(s)
Drinking Behavior/drug effects , Receptor, Cholecystokinin A/physiology , Receptors, Dopamine D2/physiology , Sucrose/administration & dosage , Sweetening Agents/administration & dosage , Taste , Analysis of Variance , Animals , Benzazepines/pharmacology , Dopamine Antagonists/pharmacology , Dose-Response Relationship, Drug , Male , Raclopride/pharmacology , Rats , Rats, Inbred OLETF , Receptor, Cholecystokinin A/deficiency , Time Factors
14.
J Gastroenterol ; 42(6): 493-6, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17671765

ABSTRACT

BACKGROUND: Gallbladder dysmotility accelerates cholelithiasis. In turn, gallbladder dysmotility can occur secondary to inflammation and excess cholesterol accumulation in gallbladder smooth muscle. METHODS: The present study was designed to determine how much gallbladder dysmotility contributes to gallstone formation as a primary cause and whether a sex difference exists in gallstone formation by comparing cholecystokinin-1 receptor gene-deficient [CCK-1R(-/-)] male and female mice. RESULTS: No sludge or gallstone formation was observed in mice at 6 months of age. The frequency of sludge and gallstone formation in mice at 12 and 24 months of age was slightly higher in female CCK-1R(-/-) mice than in males, but the difference was not significant. CONCLUSIONS: Gallbladder dysmotility may have accelerated sludge and gallstone formation, but its contribution was limited. A 12-month period was required to produce gallstones, and after the mice reached 12 months of age, further ageing did not increase the frequency of gallstones. The effect of sex did not reach a significant level.


Subject(s)
Gallstones/etiology , Receptor, Cholecystokinin A/deficiency , Age Factors , Animals , Female , Male , Mice , Receptor, Cholecystokinin A/genetics
15.
Curr Top Med Chem ; 7(12): 1205-10, 2007.
Article in English | MEDLINE | ID: mdl-17584142

ABSTRACT

Since the isolation and sequencing of cholecystokinin (CCK), considerable advances have been made in understanding the roles played by this peptide as a hormone and as a neuropeptide. CCK-1(A) and 2(B) receptor (R) cDNAs have been cloned; shortly thereafter, the naturally occurring CCK-1R gene-deficient rat (the Otsuka Long-Evans Tokushima Fatty (OLETF) rat) was discovered. This strain develops adult-onset diabetes with obesity, and has a 6847 base-pair deletion of the CCK-1R gene in which the promoter lesion and the first two exons are missing. At the same time, the genomic structures of CCK-1R in rats, mice, and humans were clarified. The CCK-1R gene consists of five exons interrupted by four introns. It has been determined that there is species- and tissue-specific CCK receptor heterogeneity of expression; in particular, there is evidence that the human pancreas does not express CCK-1R, while the pancreas in rodents primarily expresses CCK-1R. Although CCK-1R polymorphisms with amino acid changes such as 21Gly to Arg, 71 Arg to Gly, and 364 Val to Ile were discovered in subjects with obesity and diabetes mellitus, these changes occur sporadically. We identified two sequence changes, a G to T change in nucleotide -128, and an A to G change in nucleotide -81, in the promoter region of the CCK-1R gene. This polymorphism is considered to be a single nucleotide polymorphism (SNP) related to weight control difficulties in obese subjects as well as to psychiatric disorders. The precise molecular mechanisms of this polymorphism remain to be clarified.


Subject(s)
Polymorphism, Genetic/genetics , Receptor, Cholecystokinin A/genetics , Animals , Disease , Genome/genetics , Humans , Physical Chromosome Mapping , Promoter Regions, Genetic/genetics , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin A/metabolism
16.
J Pharmacol Sci ; 101(4): 280-5, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16891771

ABSTRACT

Otsuka Long-Evans Tokushima Fatty (OLETF) rats lack cholecystokinin-A receptor (CCK-AR) because of a genetic abnormality. We observed that body temperature homeostasis in response to changes in ambient temperature was deteriorated in OLETF rats, while the functions of the signal outputs from the hypothalamus to effectors were not impaired. Deteriorated homeostasis was also seen in CCK-AR deficient (-/-) mice. In the present study, we examined whether the sensory pathway involved in transmitting signals about temperature from the skin to the brain was impaired in OLETF rats. To elucidate the involvement of CCK-AR function, we conducted the same experiment in CCK-AR(-/-) mice. Responses to thermal pain were assessed using the Hargreaves' plantar test apparatus. Shortening of withdrawal latency was observed in OLETF rats compared to control rats, indicating thermal hyperalgesia. Behavioral responses following paw withdrawal were disturbed in OLETF rats. The 5-hydroxytryptamine (5-HT) and 5-hydroxyindole acetic acid contents in the hippocampus and frontal cortex of OLETF rats were significantly higher than in those of the controls. CCK-AR(-/-) mice did not show any differences from wild-type mice. In conclusion, OLETF rats showed thermal hyperalgesia and disturbed responses to thermal pain, and an alteration of 5-HT function might have a role in this disturbance.


Subject(s)
Hyperalgesia/physiopathology , Receptor, Cholecystokinin A/physiology , Acute Disease , Animals , Cerebral Cortex/metabolism , Corpus Striatum/metabolism , Dopamine/metabolism , Hippocampus/metabolism , Hydroxyindoleacetic Acid/metabolism , Hyperalgesia/etiology , Infrared Rays/adverse effects , Male , Mice , Mice, Knockout , Norepinephrine/metabolism , Pain Measurement/instrumentation , Pain Measurement/methods , Pain Threshold , Rats , Rats, Inbred OLETF , Reaction Time , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin A/genetics , Serotonin/metabolism
17.
Am J Physiol Gastrointest Liver Physiol ; 291(4): G640-9, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16728725

ABSTRACT

Obese CCK-1 receptor-lacking Otsuka Long Evans Tokushima fatty (OLETF) rats are hyperphagic relative to control, nonmutant Long Evans Tokushima Otsuka (LETO) rats. This study sought to assess whether the overeating observed in OLETF rats is associated with changes in gastric emptying rates or detection of gastric volume. We performed experiments in both 12- and 29-wk-old OLETF and LETO rats to address possible alterations in gastric functions during the development of increased body weight and blood glucose abnormalities in OLETF rats. Gastric emptying of a 5-g solid chow test meal was not significantly different between strains at either 1, 2, or 4 h postmeal. When rats with ad libitum access to chow were tested, there were no significant differences in gastric emptying between strains at any time period despite OLETF rats consuming significantly more chow than LETO rats. Similar to solid food, 5-min gastric emptying of a 5-ml isosmotic and hyperosmotic saline or glucose load was not significantly different between strains. When the stomach was distended with a 15-ml semisolid chow load, there was no significance difference in emptying at either 1 or 2 h. No significant differences in gastric emptying were detected between 12- and 29-wk-old rats under any conditions. Both young and old OLETF rats, however, reduced sham intake significantly less compared with LETO rats during a brief period of gastric distension by 5- or 10-ml balloon inflation. Finally, OLETF rats showed decreased Fos expression in the nucleus of the solitary tract relative to LETO rats after an 8-ml gastric distension. These findings demonstrate that OLETF rats do not express deficits in controlling gastric emptying rates; however, they exhibit decreased behavioral and vagal responsiveness to gastric distension that may contribute to the increased meal size in these animals.


Subject(s)
Gastric Emptying/physiology , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin A/metabolism , Stomach/physiology , Animals , Feeding Behavior/physiology , Gene Expression Regulation , Male , Rats , Rats, Inbred OLETF , Rats, Long-Evans , Receptor, Cholecystokinin A/genetics , Time Factors
18.
Am J Physiol Regul Integr Comp Physiol ; 290(1): R208-18, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16099824

ABSTRACT

Otsuka Long-Evans Tokushima fatty (OLETF) rats are a strain of Long-Evans Tokushima Otsuka (LETO) rats that do not express CCK-1 receptors, developing in adulthood, hyperphagia, obesity, and non-insulin-dependent diabetes mellitus (NIDDM). We examined weight gain and meal patterns during a 30-min independent ingestion test on postnatal days 2-4 and again on days 9-11 in OLETF and LETO rat pups. OLETF pups were significantly heavier compared with their LETO controls at both ages, and they consumed significantly more of the sweet milk diet. The difference in intake can be attributed to a significant increase in meal size and duration. Number of clusters and bursts of licking within a meal were greater in OLETF rat pups, with no difference between strains in burst and cluster size. Interlick interval (ILI) was not significantly different between OLETF and LETO pups. This measure decreased on days 9-11 compared with days 2-4 in both strains. Latency to start feeding was significantly shorter on days 2-4 in OLETF vs. LETO pups, but this difference disappeared at the second test at the older age. Two- to four-day-old OLETF pups consumed a larger volume of milk during the first minute of feeding, and their initial lick rate and decay of lick rate were significantly larger compared with their LETO controls. Lack of CCK-1 receptors, or other OLETF-related abnormalities, therefore, resulted in a satiation deficit, leading to increased meal size, hyperphagia, and increased weight gain as early as 2-4 postnatal days.


Subject(s)
Feeding Behavior/physiology , Receptor, Cholecystokinin A/deficiency , Receptor, Cholecystokinin A/metabolism , Aging , Animals , Animals, Newborn , Diet , Rats , Rats, Inbred OLETF , Rats, Long-Evans , Receptor, Cholecystokinin A/genetics , Time Factors , Weight Gain
19.
Am J Physiol Regul Integr Comp Physiol ; 289(6): R1675-86, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16081877

ABSTRACT

Otsuka Long-Evans Tokushima fatty (OLETF) rats lack the CCK-1 receptor, are hyperphagic, progressively become obese, and develop type-2 diabetes. We recently demonstrated an increased preference for both real and sham feeding of sucrose in this strain, suggesting altered orosensory sensitivity. To investigate taste functions, we used an automated gustometer with 10-s access to different concentrations of various sapid stimuli. Tests were repeated at 10 and 18 wk of age to assess the early and advanced stages of prediabetes, respectively. Compared with age-matched, nonmutant controls, the OLETF rats showed higher avidity for sucrose at both ages. This difference increased as a function of age and tastant concentration. An exaggerated response also occurred for saccharin, alanine, and fructose, but not for Polycose. Similarly, OLETF rats consumed monosodium-glutamate more at the lower concentrations compared with controls, an effect that age also accentuated. In contrast, there was no statistical strain or age differences in responses to NaCl, MgCl2, citric acid, quinine-HCl, and the trigeminal stimulus capsaicin. These findings demonstrate that compared with controls, OLETF rats differ in their gustatory functions with an overall augmented sensitivity for sweet that progresses during prediabetes. This effect explains their overconsumption of sweet solutions and may contribute to the overall hyperphagia and obesity in this strain.


Subject(s)
Body Weight , Feeding Behavior , Obesity/physiopathology , Prediabetic State/physiopathology , Receptor, Cholecystokinin A/deficiency , Taste Disorders/physiopathology , Taste , Animals , Male , Obesity/complications , Prediabetic State/complications , Rats , Rats, Long-Evans , Taste Disorders/etiology
20.
Brain Res ; 1052(1): 22-7, 2005 Aug 02.
Article in English | MEDLINE | ID: mdl-16002053

ABSTRACT

Otsuka Long-Evans Tokushima Fatty (OLETF) rats lack the CCK-1 receptor and are hyperphagic and obese. CCK-1 receptors play a role in prepulse inhibition (PPI) by modulating mesolimbic dopamine transmission, a modulator of sensorimotor gating. Therefore, the present study assessed the effects of brief, daily sucrose access on PPI and acoustic startle response (ASR) in OLETF rat and age-matched non-mutant Long-Evans Tokushima Otsuka (LETO) rats. The results revealed that OLETF rats with sucrose access showed an increased ASR [F(1,16) = 6.84; P < 0.01)], relative to sucrose receiving LETO rats. No significant sucrose effect (P = 0.283) on PPI was noted in OLETF rats, whereas sucrose receiving LETO rats had a significantly lower (P < 0.05) PPI percentage than non-sucrose controls. In contrast, sucrose-receiving OLETF rats expressed significantly higher PPI percentage than LETO rats with identical sucrose presentation (P < 0.01). Taken together, these results suggest that sucrose access alters PPI and ASR in general, and the CCK-1 receptors play a modulatory role in facilitating or inhibiting these responses, respectively. A similar effect may be contributory to the hyperphagic behavioral phenotype of obese animal models with altered central dopamine regulation.


Subject(s)
Neural Inhibition/drug effects , Obesity/physiopathology , Receptor, Cholecystokinin A/deficiency , Reflex, Acoustic/drug effects , Sucrose/pharmacology , Sweetening Agents/pharmacology , Acoustic Stimulation/methods , Animals , Animals, Genetically Modified , Feeding Behavior/physiology , Male , Obesity/genetics , Rats , Rats, Inbred OLETF , Rats, Long-Evans , Reflex, Acoustic/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...